Literature DB >> 28609801

HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies.

Karen Schreiber1,2, Karen Breen1, Hannah Cohen3, Soren Jacobsen2, Saskia Middeldorp4, Sue Pavord5, Lesley Regan6, Dario Roccatello7, Susan E Robinson1, Savino Sciascia7, Paul T Seed8, Linda Watkins9, Beverley J Hunt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28609801     DOI： 10.1055/s-0037-1603359

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  17 in total

Review 1.  Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage.

Authors:  Claire de Moreuil; Zarrin Alavi; Elisabeth Pasquier
Journal:  Br J Clin Pharmacol       Date:  2019-12-17       Impact factor: 4.335

Review 2.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

Review 3.  Update on Antiphospholipid Syndrome: Ten Topics in 2017.

Authors:  Ilaria Cavazzana; Laura Andreoli; Maarteen Limper; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2018-03-15       Impact factor: 4.592

Review 4.  Obstetric Anti-phospholipid Syndrome: State of the Art.

Authors:  Maria Chiara Gerardi; Melissa Alexandre Fernandes; Angela Tincani; Laura Andreoli
Journal:  Curr Rheumatol Rep       Date:  2018-08-13       Impact factor: 4.592

5.  Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.

Authors:  Aleena M Wojcieszek; Emily Shepherd; Philippa Middleton; Zohra S Lassi; Trish Wilson; Margaret M Murphy; Alexander Ep Heazell; David A Ellwood; Robert M Silver; Vicki Flenady
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17

6.  Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.

Authors:  Maria-Grazia Lazzaroni; Micaela Fredi; Laura Andreoli; Cecilia Beatrice Chighizola; Teresa Del Ross; Maria Gerosa; Anna Kuzenko; Maria-Gabriella Raimondo; Andrea Lojacono; Francesca Ramazzotto; Sonia Zatti; Laura Trespidi; Pier-Luigi Meroni; Vittorio Pengo; Amelia Ruffatti; Angela Tincani
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

Review 7.  The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS.

Authors:  Thomas McDonnell; Chris Wincup; Ina Buchholz; Charis Pericleous; Ian Giles; Vera Ripoll; Hannah Cohen; Mihaela Delcea; Anisur Rahman
Journal:  Blood Rev       Date:  2019-08-16       Impact factor: 10.626

8.  Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria.

Authors:  Elena Marshall; Matt Robertson; Satu Kam; Alison Penwarden; Paraskevi Riga; Nigel Davies
Journal:  Eye (Lond)       Date:  2020-06-25       Impact factor: 4.456

9.  Early Onset Severe Hypertensive Disease in Pregnancy and Screening for Antiphospholipid Syndrome.

Authors:  Nasim C Sobhani; Rachel Shulman; Erin E Tran; Juan M Gonzalez
Journal:  AJP Rep       Date:  2020-03-04

10.  16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.

Authors:  Hannah Cohen; Maria J Cuadrado; Doruk Erkan; Ali Duarte-Garcia; David A Isenberg; Jason S Knight; Thomas L Ortel; Anisur Rahman; Jane E Salmon; Maria G Tektonidou; David J Williams; Rohan Willis; Scott C Woller; Danieli Andrade
Journal:  Lupus       Date:  2020-10       Impact factor: 2.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.